2022
Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma
VAŠKŮ, Vladimír, Jan MÁCHAL, Filip ZLÁMAL a Anna VAŠKŮZákladní údaje
Originální název
Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma
Autoři
VAŠKŮ, Vladimír (203 Česká republika, domácí), Jan MÁCHAL (203 Česká republika, domácí), Filip ZLÁMAL (203 Česká republika) a Anna VAŠKŮ (203 Česká republika, garant, domácí)
Vydání
Genes, BASEL, MDPI, 2022, 2073-4425
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30109 Pathology
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.500
Kód RIV
RIV/00216224:14110/22:00128334
Organizační jednotka
Lékařská fakulta
UT WoS
000902532500001
Klíčová slova anglicky
skin T-cell lymphoma; mycosis fungoides; CTCL; polymorphism-MDR1
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 27. 1. 2023 14:08, Mgr. Tereza Miškechová
Anotace
V originále
Aim: Cutaneous T-cell lymphoma (CTCL) is a group of T-cell malignancies that develop in the skin. Though studied intensively, the etiology and pathogenesis of CTCL remain elusive. This study evaluated the survival of CTCL patients in the 1st Department of Dermatovenereology of St. Anne's University Hospital Brno. It included analysis of 19 polymorphic gene variants based on their expected involvement in CTCL severity. Material and methods: 75 patients with CTCL, evaluated and treated at the 1st Department of Dermatovenereology of St. Anne ' s University Hospital Brno, Faculty of Medicine, Masaryk University, were recruited for the study over the last 28 years (44 men and 31 women, average age 58 years, range 20-82 years). All patients were genotyped for 19 chosen gene polymorphisms by the conventional PCR method with restriction analysis. A multivariate Cox regression model was calculated to reveal genetic polymorphisms and other risk factors for survival. Results: The model identified MDR Ex21 2677 (rs2032582) as a significant genetic factor influencing the survival of the patients, with the T-allele playing a protective role. A multivariate stepwise Cox regression model confirmed the following as significant independent risk factors for overall survival: increased age at admission, clinical staging of the tumor, and male sex. Conclusion: We showed that the TT genotype at position 2677 of the MDR1 gene exhibited statistically significant longer survival in CTCL patients. As such, the TT genotype of MDR1 confers a significant advantage for the CTCL patients who respond to treatment.